AZURE_2A | R Documentation |
Kaplan-Meier digitized data from AZURE, figure 2A (PMID 25035292). A reported sample size of 3,360 for a primary endpoint of DFS in breast cancer.
AZURE_2A
A data frame of 3,359 observations and 3 variables:
time | event time (in months) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (control, zoledronic_acid) | |
Coleman R, Cameron D, Dodwell D, et al. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. Lancet Oncol 2014; 15: 997–1006.
summary(AZURE_2A)
kmplot(AZURE_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.